2nd International
Brain Technology Conference

March 11-12, Hangar 11, Tel Aviv Port, Israel

Michal Preminger, PhD

Executive Director, Harvard Office of Technology Development

passport 2013M Preminger.

Dr. Michal Preminger is currently Executive Director at Harvard University’s Office of Technology Development, overseeing industry partnerships, startup formation and development of scientific programs and discoveries emerging from research at Harvard Medical School. Prior to joining Harvard in 2005, she held a number of business development and technology development positions in the biotech and hi-tech industries, most recently as Vice President of Protein Therapeutics at Compugen, responsible for the business management of the company’s emerging drug discovery pipeline and, previously, as Director of Marketing and Business Development at Lucent Technologies. Dr. Preminger also co-founded a startup company and has been serving on the boards and scientific advisory boards of several not-for-profit, biotech, and medical device companies, including, at present, Prize4Life, Elminda, BioArray Therapeutics, FutuRx, and Medaware and, in the past, Alma Lasers and Radio Tel Aviv 102FM. Dr. Preminger holds an undergraduate degree in Medicine from the Hebrew University School of Medicine, MSc and PhD from the Weizmann Institute of Science, and an MBA from INSEAD in Fontainebleau, France.